← brief for 2026-09-21 · Slowing decline

Duration of GLP-1 Receptor Agonist Therapy and Nephrolithiasis Risk in Type 2 Diabetes: A Multicenter Retrospective Cohort Study

Preprint No results yet Not peer reviewed

Key takeaways

Who did this work

Loui Othman (Pennsylvania State University) · Annemarie Nguyen (Pennsylvania State University) · Amar Kassim (Pennsylvania State University) · Alexandra DiGiovanni (Pennsylvania State University) · Sathis Niranchchan (Pennsylvania State University) · Lakshay Khosla (Penn State Milton S. Hershey Medical Center) · Akın S. Amasyalı (Penn State Milton S. Hershey Medical Center)

Source

Preprint · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-20
https://doi.org/10.21203/rs.3.rs-10951421/v1